“Pour Money Into Your Pocket”: How To Profit From This Soon-To-Be Billion-Dollar Biotech
One billion dollars. Big things happen when a company reaches this threshold in annual sales.
5 Biotech Penny Stocks To Watch Amid An “Unfounded” Time For The Space
“The fact that more than 9 months of this year have been focused on the space is unfounded. In fact, I don’t remember one industry in recent history that has so captivated the stock market as much as this,” says the author of today’s article of the biotech space – and biotech penny stocks in particular.
Unmet Needs And Niche Markets: These Pharma Stocks Have The Momentum
While the surge in interest in pharmaceutical stocks this year has been primarily driven by factors related to the COVID-19 pandemic, the author of today’s article advises that “companies working on pharmaceutical products for unmet needs or other niche markets such as animal health could be worth a closer look.”
Which Biotech Stocks Are Best Positioned To Profit From The Gene Editing Boom?
“Many scientists believe that this year could be a breakthrough in finding cures for cancer in DNA and investors could get familiar with terms like CRISPR and precision medicine to make the most out of advancements in this space.”
Heading Into Earnings, Expectations Are Rising For These 4 Biotech Stocks
Heading into an earnings season in which many companies will be posting much lower earnings as a result of the pandemic.
3 Newly Listed Biotech Stocks – And A Look At Their Market Debuts
Three biotech companies developing therapies for the treatment of cancer and other diseases – including infectious diseases like COVID-19 – began trading on Friday.
Early Performance Of 3 Newly Listed Biotech Stocks
A trio of biotech firms IPOed on Friday – and saw double-digit gains on their trading debuts.
A Friday Flurry Of Biotech IPOs
A look at the four biotech companies going public Friday – which include two firms developing small molecule therapies to treat cancer.
3 High-Risk, High-Reward Biotech Stocks With “Millionaire-Maker Potential”
“Make no mistake: These stocks are risky. Nonetheless, each of these companies has a few factors in its favor aside from being popular with retail traders, so if you’re looking for a high-risk and high-reward stock to add to your portfolio, one of these might be worth buying,”
2 Small-Cap Contenders For The Next Big Biotech Gainers
Which biotech stocks will be the next to reward risk-tolerant investors with massive returns?